1. Home
  2. RANI vs JBDI Comparison

RANI vs JBDI Comparison

Compare RANI & JBDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RANI
  • JBDI
  • Stock Information
  • Founded
  • RANI 2012
  • JBDI 1983
  • Country
  • RANI United States
  • JBDI Singapore
  • Employees
  • RANI N/A
  • JBDI N/A
  • Industry
  • RANI Medicinal Chemicals and Botanical Products
  • JBDI
  • Sector
  • RANI Health Care
  • JBDI
  • Exchange
  • RANI Nasdaq
  • JBDI Nasdaq
  • Market Cap
  • RANI 24.2M
  • JBDI 28.7M
  • IPO Year
  • RANI 2021
  • JBDI 2024
  • Fundamental
  • Price
  • RANI $0.49
  • JBDI $2.04
  • Analyst Decision
  • RANI Strong Buy
  • JBDI
  • Analyst Count
  • RANI 4
  • JBDI 0
  • Target Price
  • RANI $7.75
  • JBDI N/A
  • AVG Volume (30 Days)
  • RANI 274.5K
  • JBDI 423.7K
  • Earning Date
  • RANI 11-13-2025
  • JBDI 01-01-0001
  • Dividend Yield
  • RANI N/A
  • JBDI N/A
  • EPS Growth
  • RANI N/A
  • JBDI N/A
  • EPS
  • RANI N/A
  • JBDI N/A
  • Revenue
  • RANI $1,200,000.00
  • JBDI $9,017,000.00
  • Revenue This Year
  • RANI N/A
  • JBDI N/A
  • Revenue Next Year
  • RANI N/A
  • JBDI N/A
  • P/E Ratio
  • RANI N/A
  • JBDI N/A
  • Revenue Growth
  • RANI N/A
  • JBDI N/A
  • 52 Week Low
  • RANI $0.39
  • JBDI $0.49
  • 52 Week High
  • RANI $3.75
  • JBDI $3.00
  • Technical
  • Relative Strength Index (RSI)
  • RANI 48.32
  • JBDI 58.76
  • Support Level
  • RANI $0.49
  • JBDI $1.53
  • Resistance Level
  • RANI $0.53
  • JBDI $2.07
  • Average True Range (ATR)
  • RANI 0.03
  • JBDI 0.21
  • MACD
  • RANI 0.00
  • JBDI -0.01
  • Stochastic Oscillator
  • RANI 45.43
  • JBDI 67.53

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

About JBDI JBDI Holdings Limited Ordinary Shares

JBDI Holdings Ltd is a supplier of Reconditioned and new Containers in Singapore. Its products include Reconditioned and new steel drums, plastic drums, carboys and IBCs.

Share on Social Networks: